Chugai Pharmaceutical Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
6/10
|
27.04 | 110.96 | -75.63% | 27.86 | -2.94% |
| P/S |
|
7.92 | 74.98 | -89.44% |
|
|
| P/BV |
|
5.41 | 70.27 | -92.29% |
|
|
| P/FCF |
|
20.56 | 85.21 | -75.87% |
|
|
| Ev/Ebitda |
|
18.68 | 17.04 | 9.61% |
|
|
| Ev/S |
|
7.52 | 72.28 | -89.6% |
|
|
| Ev/FCF |
|
24.79 | 27.12 | -8.59% |
|
|
| E/P |
|
0.047 | -0.1872 | -125.1% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
10/10
|
40.26 | -77.58 | -151.89% | 41.51 | -3.02% |
| ROE |
|
20.02 | -9.31 | -314.94% |
|
|
| ROA |
|
16.84 | -9.76 | -272.64% |
|
|
| ROIC |
|
0 | 9.09 | -100% |
|
|
| ROS |
|
29.29 | -144.19 | -120.31% |
|
|
| ROCE |
|
25.57 | 5.93 | 331.24% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0301 | -1.04 | -102.89% | 0.0304 | -0.9129% |
| Nеt Debt/Ebitda |
|
-0.9951 | 12.46 | -107.98% |
|
|
| Debt/Ratio |
|
0.007 | 0.1401 | -95.03% |
|
|
| Debt/Equity |
|
0.0101 | 24.72 | -99.96% |
|
|
| Debt/Net Income |
|
0.0413 | -1.96 | -102.11% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
5.15/10
|
2.06 | 2.68 | -23.23% | 2.11 | -2.22% |
| Number of years of dividend growth |
|
2 | 1.28 | 55.79% | ||
| DSI |
|
0.9286 | 0.7385 | 25.73% |
|
|
| Average dividend growth |
|
21.34 | -18.33 | -216.42% |
|
|
| Average percentage for 5 years |
|
2.11 | 1.91 | 10.37% |
|
|
| Average percentage for payments |
|
37.69 | 33.95 | 11% |
|
|
| Difference from average difference in sector |
|
-0.6232 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
8/10
|
61.96 | 75.4 | -17.82% | ||
| Growth impulse Ebitda in 5 years |
|
128.65 | 61.75 | 108.34% | ||
| Growth impulse Net Income in 5 years |
|
106.57 | 34.02 | 213.26% | ||
| Growth impulse FCF in 5 years |
|
130.76 | -19.39 | -774.37% | ||
| Growth impulse EPS in 5 years |
|
106.45 | -67.91 | -256.75% |
IP Score
7.44/10
